Showing results (1281-1290 of 1,310) with videos related to

Sort By:
Pageof 131
Therapeutic Advances in Musculoskeletal Disease|February 26, 2026
Three-drug combination therapy to prevent glucocorticoid-associated osteonecrosis in patients with systemic lupus erythematosus: a proof-of-concept studyGoro Motomura, Yojiro Arinobu, Hiroaki Niiro, et al.
Parasite Immunology|September 21, 2017
Dog skin parasite load, TLR-2, IL-10 and TNF-α expression and infectiousnessD C M Pereira-Fonseca, F M Oliveira-Rovai, L A C Rodas, et al.
European Heart Journal|February 2, 2015
Clinical impacts of additive use of olmesartan in hypertensive patients with chronic heart failure: the supplemental benefit of an angiotensin receptor blocker in hypertensive patients with stable heart failure using olmesartan (SUPPORT) trialYasuhiko Sakata, Nobuyuki Shiba, Jun Takahashi, et al.
Cell|September 30, 2023
An AsCas12f-based compact genome-editing tool derived by deep mutational scanning and structural analysisTomohiro Hino, Satoshi N Omura, Ryoya Nakagawa, et al.
Blood|June 26, 2023
Antibody-mediated pathogenesis of chronic GVHD through DBY/HLA class II complexes and induction of a GVL effectKento Umino, Kaoru Morita, Takashi Ikeda, et al.
Clinical and Translational Science|June 14, 2025
Evaluation of Organoid-Derived Exosomal microRNA as Liquid Biopsy for Colorectal Cancer: A Multicenter Cross-Sectional StudyAtsuhiro Sasaki, Masatake Kuroha, Masaki Tosa, et al.
Science Immunology|October 24, 2025
Lipolysis-microlipophagy cascade regulated by adipose triglyceride lipase drives pathogenic adaptive type 2 immunityHiroyuki Yagyu, Masahiro Kiuchi, Atsushi Sasaki, et al.
Scandinavian Journal of Gastroenterology|October 12, 2022
Reduced antiviral seropositivity among patients with inflammatory bowel disease treated with immunosuppressive agentsHisashi Shiga, Takahiro Takahashi, Manabu Shiraki, et al.
Nature Medicine|February 14, 2012
KIF5B-RET fusions in lung adenocarcinomaTakashi Kohno, Hitoshi Ichikawa, Yasushi Totoki, et al.
Molecular Therapy. Methods & Clinical Development|November 16, 2022
The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacsYuji Kashiwakura, Nemekhbayar Baatartsogt, Shoji Yamazaki, et al.
Pageof 131